Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.4B | 6.2B | 6.3B | 6.4B |
Cost of revenue | 3.9B | 3.8B | 3.9B | 3.9B |
Gross profit | 2.4B | 2.4B | 2.4B | 2.4B |
Operating expense | ||||
Research & development | 198M | 201M | 207M | 196M |
Selling general and admin | 1.0B | 1.0B | 1.0B | 1.0B |
Other operating expenses | — | — | — | — |
Operating income | 1.2B | 1.2B | 1.2B | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 33M | 42M | 29M | 29M |
Other income expense | 9M | -16M | 22M | 32M |
Pretax income | 1.2B | 1.2B | 1.2B | 1.2B |
Tax provision | 212M | 195M | 193M | 201M |
Net income | 965M | 971M | 1.0B | 994M |
Basic EPS | — | 2.5 | 2.5 | 2.5 |
Diluted EPS | — | 2.5 | 2.5 | 2.5 |
Basic average shares | — | 394.1M | 397.1M | 399.2M |
Diluted average shares | — | 396M | 398.9M | 401M |
EBITDA | 1.4B | 1.4B | 1.5B | 1.5B |
Net income from continuing op. | 965M | 971M | 1.0B | 994M |
Minority interests | -1M | 0 | -1M | -1M |
Preferred stock dividends | — | — | — | — |